▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collection 10.03125
▁and 1.6943359375
▁analysis 0.6806640625
▁of 0.04559326171875
▁statistical 4.203125
▁data 0.120361328125
. 0.89599609375
▁Part 4.94921875
icip 0.06683349609375
ants 0.04595947265625
▁were 0.70361328125
▁rec 3.2578125
ru 0.0010690689086914062
ited 4.839897155761719e-05
▁for 4.05078125
▁six 7.5546875
▁months 0.52197265625
▁at 3.771484375
▁two 2.498046875
▁major 5.4453125
▁pain 3.078125
▁relief 5.24609375
▁cent 1.5498046875
ers 0.07904052734375
▁in 0.70947265625
▁Israel 4.3203125
. 0.41552734375
▁The 1.1923828125
▁research 2.166015625
ers 1.505859375
▁used 2.705078125
▁The 8.0625
▁De 4.21484375
pression 0.01334381103515625
▁Module 10.1171875
▁of 0.95947265625
▁the 0.32568359375
▁Pat 2.287109375
ient 0.007503509521484375
▁Health 0.08447265625
▁Question 0.013946533203125
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73095703125
▁General 1.6826171875
ized 0.69140625
▁An 0.016021728515625
x 0.0001443624496459961
iety 0.002651214599609375
▁Dis 0.5146484375
order 0.034881591796875
▁Sc 1.205078125
ale 0.068359375
▁to 1.7373046875
▁interview 7.06640625
▁participants 2.017578125
, 3.697265625
▁evaluate 5.56640625
▁their 0.7431640625
▁answers 6.48828125
, 0.853515625
▁and 0.1422119140625
▁conduct 4.4453125
▁the 2.296875
▁study 2.2421875
. 0.224609375
▁To 5.09375
▁specifically 9.8828125
▁evaluate 2.580078125
▁and 4.35546875
▁compare 0.9423828125
▁the 0.338134765625
▁prob 11.1328125
abilities 0.1806640625
▁of 0.1295166015625
▁de 0.82421875
pression 0.03790283203125
▁or 4.5859375
▁anx 0.03558349609375
iety 0.0002944469451904297
▁among 1.7216796875
▁the 2.263671875
▁diverse 8.8984375
▁groups 1.564453125
, 1.4130859375
▁the 1.0107421875
▁study 2.673828125
▁used 1.623046875
▁multiple 4.734375
▁log 2.884765625
istic 0.03607177734375
▁regression 0.101318359375
▁analysis 0.6630859375
▁and 2.53125
▁chose 8.8984375
▁medical 7.41015625
▁mar 0.322021484375
iju 0.0015125274658203125
ana 0.00019562244415283203
▁as 0.794921875
▁the 1.083984375
▁control 2.7265625
▁group 0.5537109375
. 0.285888671875
<0x0A> 0.7548828125
The 0.96630859375
▁analysis 4.7890625
▁of 0.99609375
▁any 9.9140625
▁human 6.39453125
▁reaction 5.0234375
▁has 4.66015625
▁a 1.8046875
▁high 4.4296875
▁potential 3.50390625
▁of 1.5849609375
▁subject 5.109375
iveness 4.14453125
▁and 1.455078125
▁bias 2.369140625
, 1.8837890625
▁especially 2.34765625
▁regarding 3.93359375
▁people 4.828125
▁in 3.90625
▁severe 4.328125
▁pain 0.1947021484375
▁and 2.568359375
▁un 5.5625
stable 2.30078125
▁emot 1.033203125
ional 0.20751953125
▁condition 2.365234375
. 0.10174560546875
▁Perhaps 8.9375
▁some 4.796875
▁patients 2.396484375
▁tend 6.0546875
▁to 0.020751953125
▁ex 3.060546875
agger 0.0020427703857421875
ate 0.005695343017578125
▁their 0.76708984375
▁de 4.4921875
press 1.5107421875
ive 0.2364501953125
▁state 3.02734375
▁or 2.033203125
▁vice 7.515625
▁vers 0.021575927734375
a 8.618831634521484e-05
, 1.1494140625
▁de 6.99609375
- 5.4375
emph 1.013671875
as 0.00511932373046875
ize 0.2174072265625
▁serious 7.00390625
▁difficulties 6.34765625
. 0.9208984375
▁Because 5.88671875
▁the 2.130859375
▁survey 6.2109375
▁responses 7.265625
▁were 0.853515625
▁thoroughly 8.734375
▁anonymous 4.28515625
, 0.39794921875
▁the 1.244140625
▁research 1.55078125
ers 0.31103515625
▁were 1.3857421875
▁unable 1.8447265625
▁to 0.003223419189453125
▁carefully 8.484375
▁analyze 1.724609375
▁each 3.74609375
▁patient 2.236328125
’ 27.296875
s 0.54150390625
▁reaction 3.53125
▁and 2.494140625
▁compare 3.712890625
▁it 0.8935546875
▁to 1.0390625
▁the 0.65478515625
▁actual 5.64453125
▁states 7.359375
▁of 0.6357421875
▁condition 7.8125
. 0.358642578125
▁More 6.8046875
▁accurate 3.591796875
▁answers 4.515625
▁could 2.41015625
▁be 0.9111328125
▁obtained 0.9736328125
▁by 1.2431640625
▁professional 7.46484375
▁psych 1.923828125
olog 0.4091796875
ists 0.0014514923095703125
▁via 7.99609375
▁personal 4.21484375
▁communication 4.82421875
▁and 2.033203125
▁behavior 7.07421875
al 0.36279296875
▁analysis 2.275390625
. 0.2430419921875
▁However 2.81640625
, 0.003040313720703125
▁this 2.16015625
▁method 3.05859375
▁of 2.265625
▁research 2.26953125
▁is 1.1826171875
▁way 8.2265625
▁more 1.9423828125
▁resource 6.37109375
- 0.43017578125
int 0.53271484375
ensive 0.00830841064453125
▁and 0.68017578125
▁energy 8.921875
- 0.1422119140625
consum 0.305908203125
ing 0.002044677734375
. 0.74755859375
<0x0A> 0.84619140625
Part 5.33984375
icip 0.07965087890625
ants 0.0823974609375
▁were 0.8876953125
▁rec 1.5654296875
ru 0.0012407302856445312
ited 2.181529998779297e-05
▁for 1.1142578125
▁six 1.0810546875
▁months 0.0210723876953125
▁at 0.41357421875
▁two 0.12176513671875
▁major 0.315673828125
▁pain 0.0307769775390625
▁relief 0.0186004638671875
▁cent 0.02789306640625
ers 0.00566864013671875
▁in 0.0703125
▁Israel 0.03436279296875
. 0.180908203125
▁All 3.876953125
▁patients 1.326171875
▁experienced 5.66796875
▁chron 1.849609375
ic 0.0024852752685546875
▁pain 0.084228515625
▁for 2.955078125
▁at 0.67822265625
▁least 0.0009436607360839844
▁ 1.0126953125
3 1.46484375
▁months 0.24072265625
. 0.97265625
▁The 1.3388671875
▁study 1.888671875
▁included 2.40234375
▁ 1.005859375
8 2.84375
9 2.765625
0 3.759765625
▁participants 1.5546875
, 1.279296875
▁of 1.6806640625
▁which 0.423828125
▁ 0.1466064453125
4 1.689453125
7 2.451171875
4 2.734375
▁( 2.01171875
5 0.08514404296875
9 11.421875
%) 0.97119140625
▁were 0.505859375
▁treated 4.58984375
▁sole 6.765625
ly 0.00011301040649414062
▁with 0.5810546875
▁op 0.8095703125
io 0.398681640625
ids 0.2086181640625
, 1.2041015625
▁ 0.5419921875
3 1.1123046875
2 2.08203125
9 2.5390625
▁( 0.040069580078125
4 1.234375
1 1.240234375
%) 0.1287841796875
▁were 1.3095703125
▁treated 0.380859375
▁with 0.208740234375
▁MM 0.68505859375
, 0.2225341796875
▁and 0.1629638671875
▁ 0.13232421875
7 3.3125
7 2.41796875
▁( 0.172607421875
8 3.646484375
. 1.314453125
6 3.14453125
%) 0.0523681640625
▁acquired 9.921875
▁both 1.046875
▁( 6.8125
Fe 10.3359375
ing 2.650390625
old 0.013824462890625
▁et 1.4873046875
▁al 0.0180206298828125
., 0.292236328125
▁ 0.009033203125
2 0.19091796875
0 0.0003261566162109375
1 0.401123046875
7 2.078125
). 0.1546630859375
▁The 1.2431640625
▁remaining 6.92578125
▁ten 8.078125
▁participants 1.33203125
▁who 5.51953125
▁did 1.44140625
▁not 0.00688934326171875
▁receive 1.9814453125
▁ph 3.01171875
arma 0.053253173828125
ce 0.0011768341064453125
ut 2.2172927856445312e-05
ical 0.003299713134765625
▁op 0.7470703125
io 0.055572509765625
ids 0.0254364013671875
▁and 1.693359375
▁medical 2.544921875
▁mar 0.060211181640625
iju 0.004261016845703125
ana 8.797645568847656e-05
▁were 1.193359375
▁with 6.20703125
dra 0.1346435546875
wn 0.0001112222671508789
▁from 0.2626953125
▁the 0.0958251953125
▁analysis 4.546875
▁in 4.828125
▁the 1.203125
▁research 4.2734375
. 0.7216796875
▁Therefore 4.97265625
, 0.011688232421875
▁it 4.1875
▁is 0.93212890625
▁not 2.732421875
▁possible 0.6044921875
▁to 0.0236053466796875
▁compreh 6.58203125
ens 0.03741455078125
ively 0.00927734375
▁compare 2.0625
▁patients 4.91796875
▁taking 4.31640625
▁medic 4.26953125
ations 0.95751953125
▁with 0.97412109375
▁those 1.19140625
▁who 1.302734375
▁do 2.150390625
▁not 0.01219940185546875
. 0.86083984375
<0x0A> 0.7373046875
This 4.56640625
▁type 5.65625
▁of 0.0059814453125
▁study 1.48046875
▁is 1.3720703125
▁the 3.677734375
▁most 1.275390625
▁reve 8.3125
aling 0.0007534027099609375
▁and 0.89453125
▁inclus 6.140625
ive 0.00322723388671875
, 2.103515625
▁as 2.142578125
▁it 0.471923828125
▁contains 4.9765625
▁direct 5.80859375
▁responses 2.955078125
▁from 0.97412109375
▁a 4.1484375
▁large 1.103515625
▁number 0.56787109375
▁of 0.0031681060791015625
▁participants 1.4921875
. 0.615234375
▁All 4.140625
▁tools 9.8515625
▁in 4.6484375
▁the 0.52490234375
▁form 3.9140625
▁of 0.03680419921875
▁question 1.595703125
na 0.034423828125
ires 0.00011730194091796875
▁and 2.0
▁scales 3.029296875
▁have 3.615234375
▁already 4.3828125
▁been 0.2193603515625
▁used 2.224609375
▁and 2.01953125
▁proved 4.17578125
▁their 1.724609375
▁effic 3.625
acy 0.00011277198791503906
▁for 3.490234375
▁collect 5.2734375
ing 0.0224609375
▁analyt 8.1484375
ical 0.273193359375
▁data 0.28173828125
. 0.62353515625
▁It 3.59375
▁helps 5.15234375
▁to 0.97314453125
▁system 6.66015625
at 1.71484375
ize 0.01141357421875
▁and 1.484375
▁class 4.34765625
ify 0.002227783203125
▁distinct 8.9140625
▁kinds 6.71875
▁of 0.0199127197265625
▁information 4.171875
▁for 4.1953125
▁subsequent 4.375
▁un 7.640625
comp 5.1875
licated 0.0662841796875
▁services 12.5390625
. 0.828125
▁Thus 4.6640625
, 0.0239410400390625
▁research 4.30859375
ers 0.34228515625
▁can 1.53125
▁compare 3.732421875
▁the 1.1435546875
▁effects 2.751953125
▁of 0.09429931640625
▁medic 3.892578125
ations 0.46875
▁on 1.5712890625
▁patients 1.7666015625
▁of 4.4609375
▁diverse 4.1328125
▁age 2.708984375
▁groups 1.01953125
, 0.5908203125
▁background 4.84765625
s 0.2705078125
, 0.047760009765625
▁physical 5.06640625
▁conditions 1.3251953125
, 0.06500244140625
▁emot 3.958984375
ional 0.05303955078125
▁states 1.35546875
, 0.08905029296875
▁and 0.477783203125
▁so 2.962890625
▁on 0.265869140625
. 0.0986328125
<0x0A> 0.65380859375
The 1.08203125
▁study 1.84765625
▁conducted 4.91796875
▁a 2.587890625
▁correlation 5.71875
▁type 7.203125
▁of 0.43212890625
▁research 1.94921875
▁with 3.005859375
▁variable 8.015625
▁measures 4.640625
. 1.1796875
▁It 2.052734375
▁evaluated 4.71875
▁the 0.580078125
▁inter 6.09765625
dep 3.650390625
end 0.00048804283142089844
ence 0.0104522705078125
▁of 0.57470703125
▁various 3.7734375
▁factors 1.419921875
▁that 2.81640625
▁affected 4.21875
▁the 0.5849609375
▁physical 7.0390625
▁and 0.9716796875
▁emot 0.4541015625
ional 0.0003898143768310547
▁condition 0.8173828125
▁of 0.10662841796875
▁patients 0.6044921875
▁experien 4.421875
cing 1.811981201171875e-05
▁chron 0.5478515625
ic 0.0006237030029296875
▁pain 0.0268096923828125
. 0.236083984375
▁For 3.6171875
▁example 0.7236328125
, 0.01207733154296875
▁the 1.234375
▁survey 4.984375
▁showed 3.0703125
▁that 0.38623046875
▁the 1.7333984375
▁ratio 7.09765625
▁of 0.13720703125
▁female 4.921875
▁patients 0.81591796875
▁was 2.060546875
▁remark 9.515625
ably 0.0004558563232421875
▁higher 0.544921875
▁in 2.802734375
▁the 1.1376953125
▁op 4.453125
i 3.84765625
ates 0.0638427734375
▁group 0.274169921875
▁compared 2.81640625
▁to 0.1094970703125
▁the 0.56494140625
▁MM 0.51123046875
▁group 0.28271484375
. 0.426513671875
▁In 3.076171875
▁turn 3.91796875
, 0.0027866363525390625
▁people 6.01953125
▁on 5.5
▁op 1.3896484375
i 0.461181640625
ates 0.002796173095703125
▁were 1.1220703125
▁more 0.99560546875
▁likely 0.393310546875
▁to 0.056365966796875
▁report 3.0078125
▁major 5.98828125
▁de 0.416748046875
press 1.228515625
ive 0.00576019287109375
▁dis 0.54052734375
orders 1.2578125
. 1.7490234375
<0x0A> 2.177734375
The 1.1103515625
▁question 6.03125
na 1.587890625
ires 8.118152618408203e-05
▁used 2.05859375
▁different 8.2578125
▁variable 8.4765625
▁measures 0.79052734375
▁to 1.419921875
▁collect 2.310546875
▁information 1.8720703125
. 1.46484375
▁For 1.8349609375
▁example 0.196044921875
, 0.006809234619140625
▁it 4.06640625
▁included 2.705078125
▁compreh 8.671875
ensive 0.0270233154296875
▁so 7.08203125
cio 0.0203399658203125
- 0.4296875
dem 0.09844970703125
ographic 0.039031982421875
▁data 1.0107421875
: 5.09765625
▁gender 1.484375
, 0.08697509765625
▁age 0.2459716796875
, 0.10009765625
▁country 4.2265625
, 1.4365234375
▁type 4.28515625
▁of 0.057464599609375
▁residence 3.94921875
▁( 3.478515625
urban 2.00390625
/ 2.962890625
r 0.061248779296875
ural 0.0004944801330566406
), 0.2489013671875
▁years 5.8984375
▁of 0.1749267578125
▁education 0.697265625
, 0.1561279296875
▁and 1.8505859375
▁employ 3.6015625
ment 0.0041046142578125
▁status 0.43798828125
. 0.1827392578125
▁Pat 4.26171875
ients 0.1055908203125
▁were 1.1982421875
▁also 0.91943359375
▁asked 0.6259765625
▁about 1.1591796875
▁their 0.5908203125
▁medical 2.8515625
▁history 0.407958984375
▁over 8.8125
▁the 0.170166015625
▁years 3.82421875
▁and 1.779296875
▁the 1.806640625
▁current 3.4296875
▁presence 5.9140625
▁of 0.055877685546875
▁any 2.6796875
▁severe 4.5625
▁dise 1.4833984375
ases 6.54458999633789e-05
▁such 4.3359375
▁as 0.004085540771484375
▁heart 2.458984375
▁failure 2.068359375
, 0.1971435546875
▁di 1.865234375
ab 0.001773834228515625
etes 0.00431060791015625
, 0.12030029296875
▁ar 3.806640625
th 0.1368408203125
rit 0.0322265625
is 0.012359619140625
, 0.043426513671875
▁and 1.5771484375
▁so 0.6953125
▁on 0.03265380859375
. 0.047119140625
▁The 1.8916015625
▁third 7.23828125
▁measure 3.978515625
▁of 2.099609375
▁the 1.05078125
▁question 2.650390625
naire 0.1859130859375
▁was 0.9814453125
▁indicated 9.765625
▁by 0.63232421875
▁information 6.41015625
▁on 1.5458984375
▁any 5.21875
▁twelve 13.6484375
- 1.2509765625
month 0.329345703125
▁and 5.74609375
▁lifetime 3.197265625
▁drug 4.50390625
▁and 3.57421875
▁alco 0.09381103515625
hol 7.581710815429688e-05
▁consumption 2.431640625
. 0.45361328125
▁In 3.482421875
▁addition 0.82421875
, 0.13232421875
▁the 1.1728515625
▁record 7.82421875
▁included 1.740234375
▁a 2.525390625
▁pain 6.69140625
▁measurement 4.24609375
▁scale 1.076171875
▁from 3.607421875
▁ 0.438720703125
0 0.430419921875
▁to 0.428466796875
▁ 0.007106781005859375
1 0.0885009765625
0 0.07415771484375
▁to 4.55859375
▁evaluate 1.6376953125
▁dis 5.9609375
com 0.19580078125
fort 0.0011157989501953125
▁feelings 7.3828125
▁during 3.30078125
▁the 0.923828125
▁last 1.5234375
▁month 1.5654296875
. 0.2744140625
<0x0A> 1.0771484375
One 5.53515625
▁of 0.58837890625
▁the 0.015289306640625
▁major 2.705078125
▁limitations 2.185546875
▁is 3.3984375
▁the 0.444580078125
▁ins 5.140625
u 0.0166015625
fficient 0.111328125
ly 5.0078125
▁high 2.89453125
▁response 2.76953125
▁rate 0.08343505859375
, 2.51953125
▁ 4.55078125
5 1.8564453125
7 2.45703125
% 1.2685546875
▁instead 7.55859375
▁of 0.0054779052734375
▁ 0.85107421875
7 1.8046875
0 1.7294921875
% 1.021484375
▁( 1.6728515625
Fe 0.54931640625
ing 0.00470733642578125
old 0.0001939535140991211
▁et 0.0302734375
▁al 0.001163482666015625
., 0.007381439208984375
▁ 0.0015687942504882812
2 0.0006680488586425781
0 3.504753112792969e-05
1 0.00200653076171875
7 0.0125274658203125
). 0.04498291015625
▁It 2.7265625
▁can 3.154296875
▁be 0.399169921875
▁fairly 8.6640625
▁explained 0.8095703125
▁by 0.1376953125
▁the 0.305419921875
▁weak 8.5
▁focus 7.16796875
▁of 0.4560546875
▁respond 6.40625
ents 0.10107421875
▁who 3.744140625
▁have 3.615234375
▁overcome 8.1796875
▁severe 2.146484375
▁pain 0.491455078125
▁sens 9.109375
ations 1.119140625
▁and 1.169921875
▁de 4.09765625
press 1.8740234375
ive 0.193359375
▁episodes 3.60546875
. 0.63330078125
▁It 3.412109375
▁is 0.8134765625
▁not 2.564453125
▁clear 4.30078125
▁how 1.71875
▁to 3.513671875
▁use 5.63671875
▁these 3.16796875
▁statistics 3.421875
, 2.2890625
▁as 1.357421875
▁they 1.5078125
▁still 6.47265625
▁may 4.50390625
▁be 1.318359375
▁relevant 4.6171875
▁for 1.2978515625
▁the 1.759765625
▁overall 4.05859375
▁analysis 2.537109375
. 0.9140625
<0x0A> 1.189453125
Am 6.8671875
ong 0.02471923828125
▁all 2.658203125
▁participants 2.388671875
▁in 3.638671875
▁the 0.2474365234375
▁study 0.40283203125
, 0.07623291015625
▁ 0.6328125
4 1.76953125
2 2.66796875
. 1.4384765625
2 2.349609375
% 0.12939453125
▁suffered 4.59765625
▁from 0.135986328125
▁de 1.4130859375
pression 0.220703125
, 1.1708984375
▁and 1.9384765625
▁ 0.16748046875
3 1.6552734375
7 2.21484375
% 2.517578125
▁experienced 2.400390625
▁excess 7.6640625
ive 0.07440185546875
▁anx 0.248779296875
iety 0.0017528533935546875
. 0.4375
▁The 1.51953125
▁pl 11.1953125
ur 0.88232421875
ality 0.00012230873107910156
▁of 0.2227783203125
▁de 3.521484375
press 1.134765625
ive 0.024627685546875
▁dis 2.037109375
orders 0.03729248046875
▁among 3.712890625
▁patients 1.189453125
▁in 3.74609375
▁the 0.57421875
▁op 1.6806640625
i 1.087890625
ates 0.0034542083740234375
, 7.25390625
▁medical 2.90234375
▁mar 0.0186767578125
iju 0.00450897216796875
ana 4.088878631591797e-05
, 0.1322021484375
▁and 0.0731201171875
▁mixed 5.96875
▁OP 8.8359375
MM 5.72265625
▁groups 0.53271484375
▁number 8.0625
ed 0.010040283203125
▁ 0.1378173828125
5 2.291015625
7 2.431640625
. 0.44873046875
1 2.3828125
%, 0.26171875
▁ 0.006015777587890625
2 3.064453125
2 2.474609375
. 0.09429931640625
3 2.232421875
%, 0.1063232421875
▁and 0.0335693359375
▁ 0.0024318695068359375
5 3.302734375
1 2.47265625
. 0.1744384765625
4 2.17578125
%, 0.406005859375
▁respectively 0.00897979736328125
. 0.390869140625
▁The 1.484375
▁pl 5.1015625
ur 0.021484375
ality 3.3974647521972656e-05
▁of 0.0606689453125
▁anx 0.96484375
iety 0.0087890625
▁contained 11.046875
▁ 0.498291015625
4 1.6640625
8 2.44921875
. 0.06927490234375
4 2.314453125
% 0.5478515625
▁among 1.45703125
▁OP 6.44140625
▁patients 8.890625
, 0.25439453125
▁ 0.10260009765625
2 1.43359375
1 2.40234375
. 0.1334228515625
5 2.357421875
% 0.0113067626953125
▁among 0.390869140625
▁MM 0.3544921875
▁patients 0.253662109375
, 0.0132598876953125
▁and 0.01549530029296875
▁ 0.0361328125
3 1.25390625
8 2.677734375
. 0.1673583984375
7 2.28125
% 0.0124053955078125
▁among 0.2247314453125
▁OP 4.203125
MM 0.1695556640625
▁participants 3.623046875
. 0.29248046875
▁Pat 6.09375
ients 0.0232391357421875
▁who 2.373046875
▁took 3.15234375
▁strong 7.91015625
▁op 1.619140625
i 1.3994140625
ates 0.0037326812744140625
▁were 1.9619140625
▁t 9.078125
ended 1.2529296875
▁to 0.01611328125
▁place 10.5390625
▁their 3.681640625
▁pain 2.880859375
▁on 3.75390625
▁a 0.96337890625
▁scale 2.78515625
▁of 0.62841796875
▁ 0.35302734375
9 2.712890625
▁to 1.4326171875
▁ 0.01438140869140625
1 0.0306243896484375
0 0.07757568359375
▁( 2.3828125
Fe 1.1728515625
ing 0.004573822021484375
old 0.0005717277526855469
▁et 0.00612640380859375
▁al 0.0004734992980957031
., 0.004146575927734375
▁ 0.0010213851928710938
2 0.0002677440643310547
0 1.4424324035644531e-05
1 0.0006117820739746094
7 0.0054168701171875
). 0.044219970703125
▁They 4.31640625
▁were 1.3359375
▁also 1.388671875
▁an 8.8359375
gu 5.015625
ished 0.0268402099609375
▁em 8.4921875
otion 0.008819580078125
ally 0.0026569366455078125
▁and 1.1005859375
▁react 6.70703125
ed 0.047637939453125
▁rad 9.3671875
ically 0.0024662017822265625
▁neg 5.37109375
atively 0.0008645057678222656
▁to 0.341552734375
▁almost 5.13671875
▁all 1.2041015625
▁survey 7.16015625
▁questions 0.60302734375
. 0.310791015625
▁Pat 4.30859375
ients 0.007293701171875
▁who 1.177734375
▁took 1.537109375
▁only 5.2109375
▁MM 0.92529296875
▁or 3.146484375
▁mixed 3.912109375
▁medic 2.677734375
ations 0.32958984375
▁course 12.9609375
▁had 2.373046875
▁a 1.3046875
▁significantly 2.625
▁more 3.900390625
▁stable 3.322265625
▁emot 1.14453125
ional 0.00852203369140625
▁state 0.9111328125
▁and 1.3701171875
▁cop 5.5390625
ed 0.982421875
▁with 0.74072265625
▁pain 1.2880859375
▁more 1.7587890625
▁manage 7.04296875
able 2.435546875
. 0.51416015625
